0.63

1.61% 0.01

After Hours: .62 -0.01 -1.59%

Cyclo Therapeutics Inc (CYTH)

Overview News Price History Financials Discussions Forecast Stock Split

Cyclo Therapeutics Inc stock is traded at $0.63, with a volume of 26,548. It is up +1.61% in the last 24 hours and down -11.12% over the past month. Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

Previous Close:

$0.62

Open:

$0.632

24h Volume:

26,548

Relative Volume:

0.80

Market Cap:

$18.03M

Revenue:

$1.13M

Net Income/Loss:

$-20.74M

P/E Ratio:

-0.3351

EPS:

-1.88

Net Cash Flow:

$-18.37M

1W Performance:

+8.64%

1M Performance:

-11.12%

6M Performance:

-47.50%

1Y Performance:

-62.50%

1-Day Range:

$0.60

$0.632

1-Week Range:

$0.57

$0.6621

52-Week Range:

$0.57

$2.115

Cyclo Therapeutics Inc Stock (CYTH) Company Profile

Name

Cyclo Therapeutics Inc

Sector

Healthcare (1176)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

386-418-8060

Address

6714 NW 16TH STREET, SUITE B, GAINESVILLE

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

CYTH's Discussions on Twitter

Compare CYTH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CYTH Cyclo Therapeutics Inc	0.63	18.03M	1.13M	-20.74M	-18.37M	-0.88
ZTS Zoetis Inc	164.84	74.37B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.69	43.81B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.10	41.53B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	22.09	25.03B	16.77B	-959.00M	1.37B	-0.85
VTRS Viatris Inc	12.52	14.94B	15.05B	-883.30M	1.89B	-0.74

Cyclo Therapeutics Inc Stock (CYTH) Latest News

Dec 20, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LTRPA, LTRPB, CYTH, SKGR on Behalf of Shareholders - Benzinga

Dec 20, 2024

Dec 19, 2024

$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate MergerZUO, CYTH, PDCO, SKGR - cnhinews.com

Dec 19, 2024

Dec 16, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire

Dec 16, 2024

Dec 13, 2024

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cyclo Therapeutics, Inc.CYTH - The Eastern Progress Online

Dec 13, 2024

$HAREHOLDER ALERT: The M&A Class Action Continues To Investigate MergerAE, ZUO, CYTH, EMKR - The Eastern Progress Online

Dec 13, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARCH, CYTH, VGR on Behalf of Shareholders - The Eastern Progress Online

Dec 13, 2024

CYTH Stock Plummets to 52-Week Low of $0.59 Amid Market Challenges - Investing.com Canada

Dec 13, 2024

Dec 12, 2024

CYTH Stock Plummets to 52-Week Low of $0.59 Amid Market Challenges By Investing.com - Investing.com South Africa

Dec 12, 2024

Dec 11, 2024

Rafael Holdings: Strategic Developments and Financial Insights - TipRanks

Dec 11, 2024

Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results - The Manila Times

Dec 11, 2024

Rafael Holdings Reports Widening Losses Ahead of Strategic Cyclo Therapeutics Merger - StockTitan

Dec 11, 2024

Dec 10, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENLC, ALVR, CYTH on Behalf of Shareholders - GlobeNewswire

Dec 10, 2024

Dec 07, 2024

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of CYTH, NAPA, MNTX and MARX - The Eastern Progress Online

Dec 07, 2024

Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm - The Eastern Progress Online

Dec 07, 2024

Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm - The Eastern Progress Online

Dec 07, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, BRKH, PIRS, CFB on Behalf of Shareholders - The Eastern Progress Online

Dec 07, 2024

$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of CYTH, VBFC, CFB and MKFG - The Eastern Progress Online

Dec 07, 2024

Dec 06, 2024

$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of BFAC, BCOV, CYTH and ARCH - The Eastern Progress Online

Dec 06, 2024

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Sterling Bancorp, Inc.- SBT - The Eastern Progress Online

Dec 06, 2024

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Poseida Therapeutics, Inc.PSTX - The Eastern Progress Online

Dec 06, 2024

Dec 05, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, CYTH, ARCH on Behalf of Shareholders - GlobeNewswire

Dec 05, 2024

Dec 03, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MNTX, ARCH, CYTH on Behalf of Shareholders - Morningstar

Dec 03, 2024

Nov 29, 2024

CYTH (Cyclo Therapeutics) 3-Year Revenue Growth Rate : -51.10% (As of Sep. 2024) - GuruFocus.com

Nov 29, 2024

Nov 26, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MNTX, CFB, ARCH, CYTH on Behalf of Shareholders - Morningstar

Nov 26, 2024

Nov 24, 2024